CCO Oncology Podcast

189 Afleveringen

1. Treatment Options for Patients With Multiple Myeloma After First Relapse

   Gepubliceerd: 14-7-2021
2. Precision Medicine in Gynecologic Cancers: Expert Answers to Your Questions

   Gepubliceerd: 12-7-2021
3. Expert Answers to Questions on Managing Neurofibromatosis Type 1 and MEK Inhibitors for NF1-Associated Plexiform Neurofibromas

   Gepubliceerd: 12-7-2021
4. Expert Answers to Questions on PARP Inhibitor Combinations in Prostate Cancer

   Gepubliceerd: 30-6-2021
5. Immunotherapy for Advanced HCC: Current Options and Expert Answers to Clinician Questions

   Gepubliceerd: 29-6-2021
6. Expert Insight on Key Data From ASCO 2021 Informing Treatment for Endometrial, Ovarian, and Cervical Cancer

   Gepubliceerd: 24-6-2021
7. Optimizing Therapy for Relapsed/Refractory Multiple Myeloma: Expert Answers to Your Questions

   Gepubliceerd: 17-6-2021
8. Experts Answer FAQs on Biomarker-Driven Therapy for Non-Small-Cell Lung Cancer

   Gepubliceerd: 19-5-2021
9. Congress to Clinic: Post-ELCC Updates on Antibody–Drug Conjugates in NSCLC

   Gepubliceerd: 18-5-2021
10. Immunotherapy for Advanced HCC: Case Series

    Gepubliceerd: 17-5-2021
11. Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Germany

    Gepubliceerd: 13-5-2021
12. Managing Toxicities Associated With FGFR Inhibitors in Urothelial Cancer and Beyond

    Gepubliceerd: 4-5-2021
13. Optimizing the Timing and Sequencing of Regorafenib and TAS-102 for Patients With Metastatic Colorectal Cancer

    Gepubliceerd: 28-4-2021
14. Expert Answers to Questions on Contemporary Management of Multiple Myeloma

    Gepubliceerd: 22-4-2021
15. Combining PARP inhibitors With Other Treatments for Men With Prostate Cancer: Clinical Trial Updates

    Gepubliceerd: 19-4-2021
16. Rationale for Combining PARP Inhibitors With Other Therapies in Prostate Cancer

    Gepubliceerd: 15-4-2021
17. Expert Insight on Key Data From SGO 2021 Informing Treatment for Endometrial and Ovarian Cancer

    Gepubliceerd: 6-4-2021
18. Expert Answers to Questions on PARP Inhibition for Prostate Cancer

    Gepubliceerd: 6-4-2021
19. Expert Insights on Highlights From ASH 2020 on Lymphomas/CLL

    Gepubliceerd: 26-3-2021
20. Improving Outcomes in EGFR-Mutated Non-Small-Cell Lung Cancer: Global Insights on Evolving Practice Standards

    Gepubliceerd: 25-3-2021